A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer. Huang W, Wang C, Shen Y, Chen Q, et al. BMC Cancer 2024;24:39.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang W, Wang C, Shen Y, Chen Q, et al. A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer. BMC Cancer 2024;24:39.
PMID: 38182995